Search

Zhiqiang A Yang

age ~60

from Plainsboro, NJ

Also known as:
  • Michael Z Yang
  • Zhi Qiang Yang
  • Zhi Q Yang
  • Micheal Z Yang
  • Michael Y Ang
  • Mike Yang
  • Yang Zhiqiang
  • Zhi Qiangyang
Phone and address:
2 Rutledge Ct, Plainsboro, NJ 08536
(609)2755656

Zhiqiang Yang Phones & Addresses

  • 2 Rutledge Ct, Plainsboro, NJ 08536 • (609)2755656
  • Westlake Village, CA
  • Cockeysville, MD
  • Towson, MD
  • 102 Allison Rd #B6, Horsham, PA 19044 • (215)3239984
  • 296 Blair Mill Rd, Horsham, PA 19044 • (215)3239984
  • Knoxville, TN

Us Patents

  • 4-Fluoro-Piperidine T-Type Calcium Channel Antagonists

    view source
  • US Patent:
    8501773, Aug 6, 2013
  • Filed:
    Jun 28, 2006
  • Appl. No.:
    11/922399
  • Inventors:
    James C. Barrow - Harleysville PA, US
    Craig W. Lindsley - Brentwood TN, US
    William D. Shipe - Chalfont PA, US
    Zhiqiang Yang - Schwenksville PA, US
    David Wisnoski - Quakertown PA, US
  • Assignee:
    Merck Sharp & Dohme Corp. - Rahway NJ
  • International Classification:
    A01N 43/42
    A01N 43/40
    A61K 31/47
    A61K 31/445
    C07D 211/00
    C07D 295/00
    C07D 211/08
    C07D 401/00
    C07D 405/00
    C07D 409/00
    C07D 411/00
    C07D 413/00
    C07D 417/00
    C07D 419/00
    C07D 421/00
  • US Classification:
    514314, 514317, 546184, 546192
  • Abstract:
    The present invention is directed to 4-fluoro-piperidine compounds which are antagonists of T-type calcium channels, and which are useful in the treatment or prevention of neurological and psychiatric disorders and diseases in which T-type calcium channels are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels are involved.
  • Quinazolinone T-Type Calcium Channel Antagonists

    view source
  • US Patent:
    20080167329, Jul 10, 2008
  • Filed:
    Mar 8, 2006
  • Appl. No.:
    11/886053
  • Inventors:
    James C. Barrow - Harleysville PA, US
    Rowena V. Cube - Harleysville PA, US
    Phung Le Ngo - Lansdale PA, US
    Kenneth E. Rittle - Green Lane PA, US
    Zhiqiang Yang - Schwenksville PA, US
    Steven D. Young - Lansdale PA, US
  • International Classification:
    A61K 31/517
    C07D 239/80
    A61P 43/00
    A61P 25/08
    A61P 25/02
    A61P 25/16
    A61P 25/00
    A61P 25/18
    A61P 25/20
  • US Classification:
    51426631, 544286
  • Abstract:
    The present invention is directed to quinazolinone compounds which are antagonists of T-type calcium channels, and which are useful in the treatment or prevention of disorders and diseases in which T-type calcium channels are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels are involved.
  • Quinazolinone T-Type Calcium Channel Antagonists

    view source
  • US Patent:
    20100261741, Oct 14, 2010
  • Filed:
    Jun 28, 2010
  • Appl. No.:
    12/824702
  • Inventors:
    James C. Barrow - Harleysville PA, US
    Rowena V. Cube - Harleysville PA, US
    Phung Le Ngo - Lansdale PA, US
    Kenneth E. Rittle - Green Lane PA, US
    Zhiqiang Yang - Harleysville PA, US
    Steven D. Young - Harleysville PA, US
  • Assignee:
    Merck - Rahway NJ
  • International Classification:
    A61K 31/517
    C07D 239/82
    A61P 25/08
    A61P 25/16
    A61P 25/18
    A61P 25/22
    A61P 25/24
    A61P 25/30
    C07D 239/80
  • US Classification:
    51426631, 544286, 5142663
  • Abstract:
    The present invention is directed to quinazolinone compounds which are antagonists of T-type calcium channels, and which are useful in the treatment or prevention of disorders and diseases in which T-type calcium channels are involved. The invention is also directed to pharmaceutical compositions comprising these compounds and the use of these compounds and compositions in the prevention or treatment of such diseases in which T-type calcium channels are involved.
  • Oxazole Derivatives Useful As Modulators Of Faah

    view source
  • US Patent:
    20130018048, Jan 17, 2013
  • Filed:
    Apr 4, 2011
  • Appl. No.:
    13/635303
  • Inventors:
    ZhiQiang Yang - Schwenksville PA, US
    Philippe G. Nantermet - Lansdale PA, US
    Constantine Kreatsoulas - Elkins Park PA, US
    Keith P. Moore - Bensalem PA, US
    Evan Foster Shalen - Mill Valley CA, US
  • Assignee:
    Merck Sharp & Dohme Corp. - Rahway NJ
  • International Classification:
    C07D 263/46
    A61P 19/02
    A61P 29/00
    A61P 25/00
    A61P 25/06
    A61P 25/20
    A61P 25/28
    A61P 25/16
    C07D 413/14
    C07D 471/04
    C07D 491/08
    C07D 417/14
    C07D 487/04
    C07D 413/04
    A61K 31/444
    A61K 31/4545
    A61K 31/506
    A61K 31/4439
    A61K 31/5377
    A61K 31/496
    A61K 31/437
    A61K 31/422
    A61K 31/541
    A61K 31/433
    A61K 31/4245
    A61K 31/427
    A61K 31/421
  • US Classification:
    5142278, 548228, 514376, 546256, 546194, 544316, 5462714, 544131, 544364, 546113, 546119, 544331, 544369, 544137, 544 582, 548138, 548143, 548200, 514333, 514318, 514274, 514340, 5142368, 5142531, 514300, 514303, 514275, 51425402, 514363, 514364, 514365
  • Abstract:
    The present invention is directed to certain Oxazole derivatives which are useful as modulators of Fatty Acid Amide Hydrolase (FAAH) and as FAAH imaging agents. The invention is also concerned with pharmaceutical formulations comprising these compounds as active ingredients and the use of the compounds and their formulations in the treatment of certain disorders, including osteoarthritis, rheumatoid arthritis, diabetic neuropathy, postherpetic neuralgia, skeletomuscular pain, and fibromyalgia, as well as acute pain, migraine, sleep disorder, Alzheimer Disease, and Parkinson's Disease.
  • Carbamate And Urea Compounds As Multikinase Inhibitors

    view source
  • US Patent:
    20210163445, Jun 3, 2021
  • Filed:
    Dec 10, 2018
  • Appl. No.:
    16/770697
  • Inventors:
    - North Brunswick NJ, US
    Zhiqiang Yang - Westfield NJ, US
    Francis Lee - Yardley PA, US
    John Qiang Tan - North Brunswick NJ, US
  • International Classification:
    C07D 401/12
    C07D 215/22
    C07D 487/04
    C07D 487/08
    C07D 403/12
  • Abstract:
    The present disclosure describes carbamate and urea compounds as novel multikinase inhibitors and methods for preparing them. The pharmaceutical compositions comprising such multikinase inhibitors and methods of using them for treating cancer, infectious diseases, and other disorders associated with kinases are also described.
  • Macrocyclic Compounds As Trk Kinase Inhibitors And Uses Thereof

    view source
  • US Patent:
    20200385386, Dec 10, 2020
  • Filed:
    Oct 11, 2018
  • Appl. No.:
    16/760790
  • Inventors:
    - North Brunswick NJ, US
    Zhiqiang Yang - Westfield NJ, US
    Francis Lee - Yardley PA, US
    John Qiang Tan - North Brunswick NJ, US
  • International Classification:
    C07D 471/22
    C07D 487/22
    C07D 498/22
  • Abstract:
    The present disclosure describes novel TRK kinase inhibitors and methods for preparing them. The pharmaceutical compositions comprising such TRK kinase inhibitors and methods of using them for treating cancer, infectious diseases, and other disorders are also described.
  • Heterocyclic Compounds As Prmt5 Inhibitors

    view source
  • US Patent:
    20200369667, Nov 26, 2020
  • Filed:
    Nov 1, 2018
  • Appl. No.:
    16/767077
  • Inventors:
    - North Brunswick NJ, US
    Zhiqiang Yang - Westfield NJ, US
    Francis Lee - Yardley PA, US
    John Qiang Tan - North Brunswick NJ, US
  • International Classification:
    C07D 487/04
    C07D 519/00
    C07H 19/14
  • Abstract:
    The present disclosure describes novel PRMT5 inhibitors and methods for preparing them. The pharmaceutical compositions comprising such PRMTS inhibitors and methods of using them for treating cancer, infectious diseases, and other PRMTS associated disorders are also described.
  • Cyclic Compounds As Immunomodulating Agents

    view source
  • US Patent:
    20200239464, Jul 30, 2020
  • Filed:
    Sep 5, 2018
  • Appl. No.:
    16/648213
  • Inventors:
    - North Brunswick NJ, US
    Zhiqiang Yang - Westfield NJ, US
    Francis Lee - Yardley PA, US
    John Qiang Tan - North Brunswick NJ, US
  • International Classification:
    C07D 471/04
    C07D 215/14
    C07D 401/08
    C07D 401/12
    C07D 401/04
  • Abstract:
    The present disclosure describes novel IDO inhibitors and methods for preparing them. The pharmaceutical compositions comprising such IDO inhibitors and methods of using them for treating cancer, infectious diseases, and other disorders are also described

Resumes

Zhiqiang Yang Photo 1

Zhiqiang Yang

view source

Youtube

Zhiqiang Yang - Mapping and Monitoring Large ...

Presenter: Zhiqiang Yang, Oregon State University Title: Mapping and M...

  • Duration:
    2m 56s

Primordial Qigong - Grandmaster Feng Zhiqiang

Tai Chi Grandmaster Feng Zhiqiang of Beijing, China was also a master ...

  • Duration:
    15m 18s

6 January 2023

  • Duration:
    16s

xinyihunyuan Feng Zhiqiang

De term Hunyuan heeft verschillende betekenissen en niveaus. De letter...

  • Duration:
    12m 6s

Feng Zhiqiang

application/push...

  • Duration:
    7m 8s

Yang Zhiqiang Detains Incumbent MP Huang Lizhao

The common point of 5 detainees is "gold flow"! "From the donor to the...

  • Duration:
    14m 37s

Googleplus

Zhiqiang Yang Photo 2

Zhiqiang Yang

Work:
Mcc
Zhiqiang Yang Photo 3

Zhiqiang Yang

Zhiqiang Yang Photo 4

Zhiqiang Yang

Tagline:
True
Zhiqiang Yang Photo 5

Zhiqiang Yang

Facebook

Zhiqiang Yang Photo 6

Zhiqiang Yang Charlotte NC

view source
Zhiqiang Yang (Charlotte, NC)
Zhiqiang Yang Photo 7

Yang Zhiqiang China

view source
Zhiqiang Yang Photo 8

Zhiqiang Yang China

view source

Get Report for Zhiqiang A Yang from Plainsboro, NJ, age ~60
Control profile